S. Murray Yule

1.0k total citations
21 papers, 784 citations indexed

About

S. Murray Yule is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S. Murray Yule has authored 21 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S. Murray Yule's work include Acute Lymphoblastic Leukemia research (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). S. Murray Yule is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). S. Murray Yule collaborates with scholars based in United Kingdom, Netherlands and Belgium. S. Murray Yule's co-authors include Alan V. Boddy, L Price, Andrew D.J. Pearson, Jeffrey R. Idle, Ruth Wyllie, Michael Cole, M Tasso, EJ Estlin, A D Pearson and Alex D. McMahon and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

S. Murray Yule

21 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Murray Yule United Kingdom 16 266 254 233 178 133 21 784
Susan P. Carpenter United States 14 157 0.6× 139 0.5× 157 0.7× 110 0.6× 55 0.4× 20 839
Julie Errington United Kingdom 16 303 1.1× 71 0.3× 158 0.7× 85 0.5× 109 0.8× 25 573
A.S.T. Planting Netherlands 19 333 1.3× 254 1.0× 681 2.9× 81 0.5× 90 0.7× 31 1.2k
Rob Pieters Netherlands 15 352 1.3× 46 0.2× 342 1.5× 338 1.9× 179 1.3× 27 957
Miki Nishimura Japan 18 422 1.6× 85 0.3× 264 1.1× 82 0.5× 102 0.8× 49 1.1k
P. Brent Ferrell United States 17 325 1.2× 179 0.7× 264 1.1× 34 0.2× 61 0.5× 49 1.1k
John F. DiJoseph United States 24 455 1.7× 255 1.0× 739 3.2× 195 1.1× 43 0.3× 45 1.5k
Young Cw United States 12 640 2.4× 136 0.5× 170 0.7× 80 0.4× 39 0.3× 22 972
Susan Walther United States 11 245 0.9× 28 0.1× 272 1.2× 84 0.5× 131 1.0× 17 693
Bertino United States 11 178 0.7× 70 0.3× 190 0.8× 130 0.7× 38 0.3× 27 520

Countries citing papers authored by S. Murray Yule

Since Specialization
Citations

This map shows the geographic impact of S. Murray Yule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Murray Yule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Murray Yule more than expected).

Fields of papers citing papers by S. Murray Yule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Murray Yule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Murray Yule. The network helps show where S. Murray Yule may publish in the future.

Co-authorship network of co-authors of S. Murray Yule

This figure shows the co-authorship network connecting the top 25 collaborators of S. Murray Yule. A scholar is included among the top collaborators of S. Murray Yule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Murray Yule. S. Murray Yule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talbot, Denis, Joachim von Pawel, Emma Cattell, et al.. (2007). A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 13(6). 1816–1822. 52 indexed citations
2.
Beumer, Jan H., M. J. X. Hillebrand, Dick Pluim, et al.. (2005). Human metabolism of [14C]indisulam following i.v. infusion in cancer patients. Investigational New Drugs. 23(4). 317–330. 7 indexed citations
3.
Kesteren, Charlotte van, Anthe S. Zandvliet, Mats O. Karlsson, et al.. (2005). Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam. Investigational New Drugs. 23(3). 225–234. 47 indexed citations
4.
5.
Yule, S. Murray. (2001). Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioning. Archives of Disease in Childhood. 84(1). 61–64. 31 indexed citations
6.
7.
Veal, Gareth J., Melanie Griffin, Elizabeth E. Price, et al.. (2001). A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin. British Journal of Cancer. 84(8). 1029–1035. 59 indexed citations
8.
Estlin, EJ, Milind Ronghe, G.A. Amos Burke, & S. Murray Yule. (2000). The Clinical and Cellular Pharmacology Of Vincristine, Corticosteroids, l‐Asparaginase, Anthracyclines and Cyclophosphamide In Relation To Childhood Acute Lymphoblastic Leukaemia. British Journal of Haematology. 110(4). 780–790. 26 indexed citations
9.
Boddy, Alan V. & S. Murray Yule. (2000). Metabolism and Pharmacokinetics of Oxazaphosphorines. Clinical Pharmacokinetics. 38(4). 291–304. 163 indexed citations
10.
Yule, S. Murray, et al.. (1999). Cyclophosphamide metabolism in children with Fanconi’s anaemia. Bone Marrow Transplantation. 24(2). 123–128. 15 indexed citations
11.
Yule, S. Murray, Dianne Walker, Michael Cole, et al.. (1999). The Effect of Fluconazole on Cyclophosphamide Metabolism in Children. Drug Metabolism and Disposition. 27(3). 417–421. 27 indexed citations
12.
Yule, S. Murray, L Price, Andrew D.J. Pearson, & Alan V. Boddy. (1997). Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.. PubMed. 3(11). 1985–92. 42 indexed citations
13.
Yule, S. Murray, et al.. (1997). High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study.. Journal of Clinical Oncology. 15(10). 3258–3265. 18 indexed citations
14.
Boddy, Alan V., S. Murray Yule, Ruth Wyllie, et al.. (1996). Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration. Cancer Chemotherapy and Pharmacology. 38(2). 147–154. 27 indexed citations
15.
Yule, S. Murray, Alan V. Boddy, Michael Cole, et al.. (1996). Cyclophosphamide pharmacokinetics in children. British Journal of Clinical Pharmacology. 41(1). 13–19. 70 indexed citations
16.
Yule, S. Murray, et al.. (1995). Solid alveolar rhabdomyosarcoma with a t(2;13). Cancer Genetics and Cytogenetics. 80(2). 107–109. 9 indexed citations
17.
Boddy, Alan V., S. Murray Yule, Ruth Wyllie, et al.. (1995). Comparison of continuous infusion and bolus administration of ifosfamide in children. European Journal of Cancer. 31(5). 785–790. 35 indexed citations
18.
Yule, S. Murray, Alan V. Boddy, Michael Cole, et al.. (1995). Cyclophosphamide metabolism in children.. PubMed. 55(4). 803–9. 51 indexed citations
19.
Yule, S. Murray, Patrick Dawes, A J Malcolm, & A. D. J. Pearson. (1994). Occurrence of Seminoma and Dysgerminoma in Father and Daughter. Pediatric Hematology and Oncology. 11(2). 211–213. 4 indexed citations
20.
Boddy, Alan V., S. Murray Yule, Ruth Wyllie, et al.. (1993). Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.. PubMed. 53(16). 3758–64. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan P. Carpenter Breakdown of academic impact, for papers by Julie Errington Breakdown of academic impact, for papers by A.S.T. Planting Breakdown of academic impact, for papers by Rob Pieters Breakdown of academic impact, for papers by Miki Nishimura Breakdown of academic impact, for papers by P. Brent Ferrell Breakdown of academic impact, for papers by John F. DiJoseph Breakdown of academic impact, for papers by Young Cw Breakdown of academic impact, for papers by Susan Walther Breakdown of academic impact, for papers by Bertino
Rankless by CCL
2026